Related references
Note: Only part of the references are listed.Angiogenesis and chronic kidney disease
Yohei Maeshima et al.
FIBROGENESIS & TISSUE REPAIR (2010)
Using Median Regression to Obtain Adjusted Estimates of Central Tendency for Skewed Laboratory and Epidemiologic Data
Katharine M. McGreevy et al.
CLINICAL CHEMISTRY (2009)
Angiogenesis in the kidney: a new therapeutic target?
Lilach O. Lerman et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2009)
Emerging risk factors and markers of chronic kidney disease progression
Florian Kronenberg
NATURE REVIEWS NEPHROLOGY (2009)
A defective angiogenesis in chronic kidney disease
Narisa Futrakul et al.
RENAL FAILURE (2008)
Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition
Adelina Stoessel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Chronic NOS inhibition actuates endothelial- mesenchymal transformation
Edmond O'Riordan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
Body surface area in normal-weight, overweight, and obese adults. A comparison study
J Verbraecken et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model
K Ichinose et al.
DIABETES (2005)
Recommendations for blood pressure measurement in humans and experimental animals - Part 1: Blood pressure measurement in humans - A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research
TG Pickering et al.
CIRCULATION (2005)
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
NH Kim et al.
KIDNEY INTERNATIONAL (2005)
Improved biological activity of a mutant endostatin containing a single amino-acid substitution
Y Yokoyama et al.
BRITISH JOURNAL OF CANCER (2004)
Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis
A Shimizu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1
J Hanai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis
Y Masuda et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development
AS Woolf et al.
PEDIATRIC NEPHROLOGY (2001)
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy
P Hovind et al.
KIDNEY INTERNATIONAL (2000)